Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 107055

In scope icon M 7 E
QID 107055 (Type "107055" in App Search)
A 31-year-old female presents to the emergency department with sudden onset right-hand weakness. She denies pain or previous similar episodes. On further questioning, she notes sudden, painful loss of vision several months earlier. Her vision is currently back to baseline. An MRI is performed, which is shown in Figure A. Which of the following is the most appropriate next step?
  • A

Administer beta-interferon and admit to hospital

27%

7/26

Administer high-dose IV solumedrol and admit to hospital

46%

12/26

Prescribe oral prednisone and schedule follow-up in 2 weeks

19%

5/26

Prescribe riluzone and schedule follow-up in 3 days

0%

0/26

Order electromyography testing

0%

0/26

  • A

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient's clinical presentation is consistent with a multiple sclerosis (MS) flare, which should be treated with high-dose IV solumedrol and hospital admission.

Multiple sclerosis (MS) is a demyelinating disease with likely autoimmune pathophysiology. Patients often present with a history of multiple episodes of self-resolving neurological symptoms, such as limb weakness or optic neuritis. Symptom prophylaxis typically includes beta-interferons and immunosuppressants, while high-dose, IV steroids are the cornerstone of treatment for acute flares. The overall prognosis ranges from prolonged remission to rapid death.

Nicholas and Rashid review MS. They note that early MS is relapsing-remitting in 90% of patients. However, most patients experience a primary progressive course within 6-10 years of onset. Many patients live with MS for 30 or more years, and the overall life expectancy in patients with MS is not significantly reduced.

Alvermann et al. perform a review of cerebrospinal fluid (CSF) findings in MS. They note that, while nearly every study notes CSF pleiocytosis, specific immunotyping may offer further specificity for diagnosing MS and its prognosis. Of note, some studies have shown increased T-helper cells and T-regulatory cells in CSF in patients with MS.

Figure A shows Dawson's fingers: white, finger-like protrusions perpendicular from the ventricles. Illustration A shows the patterns of progression in MS. Illustration B shows optic neuritis, which typically presents without abnormalities on fundal exam but may show a swollen optic disc, as is seen in this photo.

Incorrect Answers:
Answer 1: Interferon beta is used for symptom prophylaxis, not for acute flares.
Answer 3: Steroids should be given intravenously, not orally, for MS flare-ups.
Answer 4: Riluzole is used to slow progression of amyotrophic lateral sclerosis (ALS). Its mechanism of action is to decrease presynaptic glutamate release.
Answer 5: EMGs are performed to diagnose muscle disorders, such as muscular dystrophy or polymyositis, nerve disorders such as myasthenia gravis, carpal tunnel syndrome, and ALS among others.

ILLUSTRATIONS:
REFERENCES (2)
Authors
Rating
Please Rate Question Quality

1.5

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(2)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options